Trial NCT02829814

View at ClinicalTrials.gov 
Org. Study IDs: TNX-CY-F302

Last trial update was posted on 2018-04-25

MeSH Interventions

Cyclobenzaprine

MeSH Conditions

Collagen Diseases Fibromyalgia Muscular Diseases Musculoskeletal Diseases Myofascial Pain Syndromes Nervous System Diseases Neuromuscular Diseases Rheumatic Diseases

Other Conditions


Stopping Reasons

For business reason unrelated to safety or tolerability,Tonix has discontinued the Fibromyalgia development with TNX102 SL.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID